The Child Mind Institute, a leading nonprofit focused on children's mental health, appointed Dr. Vera Feuer as its first Chief Clinical Officer. Feuer brings over 20 years of clinical leadership in pediatric and adolescent psychiatry to the role.

This inaugural position reflects the institute's commitment to strengthening clinical care and research for children struggling with mental health disorders. As CCO, Feuer will oversee clinical operations, treatment protocols, and evidence-based programs serving children and families across the organization's services.

The Child Mind Institute serves thousands of children annually through therapy, medication management, evaluations, and specialized programs for conditions including anxiety, depression, ADHD, and autism. The organization operates multiple locations and offers both in-person and teletherapy options, making mental health care more accessible to families who need it.

Feuer's extensive background positions her to bridge clinical practice with organizational strategy. Her appointment signals the institute's focus on delivering high-quality, research-backed treatment during a time when childhood mental health needs remain urgent. The American Academy of Pediatrics and the American Psychological Association have both documented rising rates of anxiety and depression in children and teens, making leadership like Feuer's clinical expertise increasingly valuable.

Parents seeking mental health support for their children can look to organizations like the Child Mind Institute for comprehensive evaluations and treatment plans tailored to individual needs. The institute's clinician-led approach ensures that care recommendations stem from deep clinical experience rather than administrative decision-making alone.

For families navigating a child's mental health concerns, having experienced clinical leadership at major treatment organizations provides confidence that programs are grounded in current research and best practices. Parents can ask potential providers about their clinical director's background and the organization's commitment to evidence-based treatment when evaluating care options.